2023 Fiscal Year Annual Research Report
Breast cancer tumors in deep tissue imaging with bi-modal NIR/MRI probe
| Project/Area Number |
21K15577
|
|---|
| Research Institution | Kawasaki Institute of Industrial Promotion Innovation Center of NanoMedicine |
|---|
Principal Investigator |
ドアン テイキンユン 公益財団法人川崎市産業振興財団(ナノ医療イノベーションセンター), ナノ医療イノベーションセンター, 研究員 (70838870)
|
|---|
| Project Period (FY) |
2021-04-01 – 2024-03-31
|
| Keywords | HER2 / MRI / NIR / IR-1061 / Gd-DOTA |
|---|
| Outline of Annual Research Achievements |
A HER2 targeting bi-modal MRI/NIR-II micelles with a diameter about 30 nm has been developed. Antibodies were bound to the probe through their amine groups on carboxyl-functionalized micelles via EDC/NHS chemistry. The ratios of coupling carboxyl groups on accessibility of immobilized anti-bodies and detection limits of specific antibody-antigen affinity were examined. Bimodal imaging probes with different coupling ratios of antibodies on their surface were investigated to determine the optimal surface density. Assays of target-binding abilities of the Herceptin-bound probes were obtained when various concentrations of micelles were applied for specific detection of antigens. Targeting ability was verified with fluorescence imag-es of SKBR-3 and MCF-7 cells incubated with these probes.
|
